Gastroenterology
Volume 123, Issue 4 , Pages 1129-1134, October 2002

Cannabinoid receptor agonism inhibits transient lower esophageal sphincter relaxations and reflux in dogs☆☆☆

*Gastrointestinal Biology, Integrative Pharmacology, AstraZeneca R&D Mölndal, Mölndal, Sweden; and ‡Nerve-Gut Research Laboratory, Department of Gastroenterology, Hepatology and General Medicine, Royal Adelaide Hospital and Department of Medicine, University of Adelaide, Adelaide, Australia

Received 14 March 2002; accepted 20 June 2002.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 30.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

☆ Address requests for reprints to: Anders Lehmann, Ph.D., Gastrointestinal Biology, Integrative Pharmacology, AstraZeneca R&D Mölndal, S-431 83 Mölndal, Sweden. e-mail Anders.Lehmann@astrazeneca.com; fax: (46) 31 776 3747.

☆☆ Supported by AstraZeneca R&D Mölndal.

PII: S0016-5085(02)00218-4

doi:10.1053/gast.2002.36025

Gastroenterology
Volume 123, Issue 4 , Pages 1129-1134, October 2002

Article Tools

* Image Usage & Resolution